GNRH1 and ovarian hyperstimulation syndrome: The advantage of short treatment duration, along with GnRHa as a trigger almost eliminating the risk of OHSS [10], has led the GnRH antagonist protocol to be a mainstay in fertility preservation for cancer patients [11, 12] and, later, in elective fertility preservation.